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ABSTRACT
Objective: to develop and validate a nursing care protocol for patients with a ventricular assist device (VAD). Method: 
descriptive study, with a quantitative approach, for an instrument’s methodological validation. Three stages were conducted: 
development of the instrument; protocol content validation according to the Delphi technique, and agreement among experts 
and the scientifi c literature.  Results: based on the content validation, a care protocol for patients with a VAD was created and 
assessed by Spanish experts. Of the 15 items evaluated by means of the content validity index (CVI), 10 presented solid evidence 
of validation, with Kappa ranging between 0.87 and 1. Conclusion: the method enabled the validation of interventions that will 
contribute to qualifi ed and standardized care for patients with a VAD. 
Descriptors: Heart Failure; Assisted Circulation; Validation Studies; Protocols; Nursing Care.
RESUMO
Objetivo: elaborar e validar um protocolo de cuidados de enfermagem a pacientes com dispositivo de assistência ventricular 
(DAV). Método: estudo descritivo, com abordagem quantitativa de validação metodológica de instrumento. Seguiram-se três 
etapas: elaboração do instrumento; validação do conteúdo do protocolo segundo a técnica de Delphi e concordância entre 
peritos e a literatura científi ca. Resultados: com base na validação do conteúdo, elaborou-se um protocolo referente aos cuidados 
a paciente em uso de DAV avaliado por peritos/juízes espanhóis. Dos 15 itens avaliados, por meio do Índice de Validade de 
Conteúdo (IVC), 10 deles apresentaram forte evidência de validação com Kappa que variaram de 0,87 a 1. Conclusão: o método 
permitiu validar intervenções que contribuirão para um cuidado qualifi cado e uniformizado a pacientes em uso de DAV. 
Descritores: Insufi ciência Cardíaca; Circulação Assistida; Estudos de Validação; Protocolos; Cuidados de Enfermagem.
RESUMEN
Objetivo: elaborar y validar un protocolo de atención de enfermería a pacientes con dispositivo de asistencia ventricular (DAV). 
Método: estudio descriptivo, con abordaje cuantitativo, de validación metodológica de instrumento. Se siguieron tres etapas: 
elaboración del instrumento; validación del contenido del protocolo según técnica de Delphi y concordancia entre expertos 
y la literatura científi ca. Resultados: en base a la validación del contenido, se elaboró un protocolo referido a la atención de 
pacientes en uso de DAV, evaluado por expertos/jueces españoles. De los 15 ítems evaluados, mediante el índice de Validez 
de Contenido (IVC), 10 de ellos presentaron fuerte evidencia de validación con Kappa, variando entre 0,87 y 1. Conclusión: 
el método permitió validar intervenciones que contribuirán a una atención califi cada y uniforme a pacientes en uso de DAV. 
Descriptores: Insufi ciencia Cardíaca; Circulación Asistida; Estudios de Validación; Protocolos; Atención de Enfermería. 
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INTRODUCTION
The changes brought about by the industrialization of soci-
ety and urbanization processes have led to changes in eating 
habits, sedentary lifestyle, obesity, and smoking habits in the 
population. Such changes are responsible for the increased 
incidence of cardiovascular diseases. Two million new cases 
of heart failure (HF) are diagnosed every year in developed 
countries, w twenty-three million people are affected globally, 
representing a major public health problem(1-2).
Heart failure is a progressive condition of the cardiac muscle 
with frequent situations of immunological, mechanical, neu-
rohormonal, and ischemic disorders that may cause changes 
in the structure of the pericardium and cardiac endothelium(2).
The literature classifies the types of HF in left and right. The 
left dysfunction presents reduced contractility of the left ven-
tricle (LV) with subsequent reduction of the cardiac output and 
ejection fraction (EF). The right dysfunction presents no pulmo-
nary edema and presence of signs of systemic congestion (jugu-
lar distension, hepatomegaly, ascites, lower limb edema)(2-3).
Heart failure is caused by hypertension, ischemia (coronary 
artery disease), valvular dysfunction, and cardiomyopathies, 
such as Chagas, hyperthropic, idiopathic, restrictive, and alco-
holic ones(1-2). Hypertension and dilated cardiomyopathy are 
relevant factors in the evolution of HF. Ischemia is one of the 
most common causes of decompensated HF as it causes a re-
duction in the myocardial contractility(2).
Patients with HF presenting hemodynamic instability re-
quire periodical hospitalizations in order to improve their 
clinical condition through the use of inotropic agents and 
mechanical circulatory support (MCS), such as ventricular 
assist devices (VADs)(4).
There are different types of VADs, such as percutaneous VADs, 
which are indicated for short-term use and may be inserted in the 
laboratory through the use of catheters, as a strategy to stabilize 
patients with acute cardiogenic shock. Long-term VADs are those 
surgically implanted and designed to increase the lifespan and/or 
as a bridge for transplantation. Moreover, VADs may be used to 
support the deficit of the right ventricle, left ventricle, or both(4).
The main function of VADs consists in ensuring an effec-
tive systemic perfusion, avoiding multiple organs dysfunction, 
providing improvement of the cardiac output and pulmonary 
edema, reducing the central venous pressure, and reducing 
the neurohormonal activity activated by the HF. They are char-
acterized according to their use, subdivided in counterpulsa-
tion support (intra-aortic balloon pump) and parallel assist 
(artificial ventricles)(5-6).
Extracorporeal membrane oxygenation (ECMO) is a short-
acting MCS system indicated for cardiogenic shock and respi-
ratory failure when surgical or conventional therapeutic pro-
cedures, including the use of an intra-aortic balloon pump, 
are not successful. In addition to being more economical than 
other VADs(7), it provides ventricular support and is effective 
as a “bridge” for heart transplantation.
The Levitronix CentriMag is another short-term ventricu-
lar assist device characterized by an extracorporeal pump 
presenting an engine, a console, a blood flow probe, and a 
circuit. Its main advantages include ease of use, excellent reli-
ability, and low risk of thrombosis(8).
Despite the existence of studies addressing topics related 
to the care of patients using ventricular assist devices, there is 
no standardization of such care. Thus, this study points out the 
possibility of developing a practical and systematized instru-
ment based on the analysis of agreement among evaluators.
A care protocol for patients using ventricular assist devices 
primarily aims at preventing complications resulting from the 
use of the device, such as thromboembolism, bleeding, limb 
ischemia, and infections. The objective of this study was to 
develop and validate a nursing care protocol for patients with 
a ventricular assist device.
METHOD
Ethical aspects
The protocol was submitted to the Biomedical Research Ethics 
Committee of the Polytechnic Teaching Hospital La Fé, in Valencia, 
Spain. All participants signed a free and informed consent form.
Study design, setting, and period
A descriptive study, using a quantitative approach, was 
conducted for methodological validation of an instrument. 
Three methodological stages were followed: instrument 
development; protocol content validation according to the 
Delphi technique, and agreement among experts and the 
scientific literature. 
The study was conducted in a teaching hospital in the city 
of Valencia, Spain, between November 2012 and April 2013.
Sample and inclusion and exclusion criteria
The sample of individuals that make up the board of ex-
perts for the present study consisted of nurses working in the 
intensive care services of the mentioned hospital. Inclusion 
criteria were: being a nurse with minimum practical experi-
ence of one year in the care of patients using a VAD. Con-
venience sampling was used. Thus, contact to and selection 
of the sample were performed by “snowball sampling”, in 
which the subjects participating in the research indicated 
other subjects. 
Study protocol
The Delphi technique was used to validate the content. 
This technique consists in collecting data, tabulating, and as-
sessing a given theme by means of the opinion of experts in 
the area. This validation criterion consists in the convergent 
opinion of the experts and emphasizes the need for a consen-
sus among the group of participants(9).
Judging means evaluating, giving an opinion; transforming 
something into the object of a process or demand(10). Valida-
tion consists in a subjective way of evaluation and keeps the 
concern of the experts in assessing the instrument in relation 
to the clarity of its items, ease of reading, understanding, and 
presentation of the variables(9-10).
Validation through an examination board was used. It con-
sists in a strategy based on the set of scientific knowledge of 
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professionals for the development of products, material or not, 
in order to evaluate a given practical situation.
Searches in the scientific literature(4-8,11-16) were conducted 
for the elaboration of the protocol and to carry out the discus-
sion of the variables related to the patient using a ventricle 
assist device.
In the first stage of the Delphi, one of the Spanish re-
searchers contacted, at her work place, nursing professionals 
of a university hospital in Valencia, Spain; in total, she pro-
vided the data collection instrument to 115 nurses that met 
the inclusion criteria, with concomitant clarification on the 
aims, filling, and purpose of the study, between November 
2012 and January 2013. A deadline of 30 days was set for 
analysis and return of the instrument. At the end of the dead-
line, 42 experts returned the instrument duly completed. The 
work technique consisted in the individual filling of the form 
(instrument), with a space for suggestions and without the 
presence of the researchers in order to configure their non-
interference in the answers.
The experts performed the assessment through the use of 
a Likert scale, with three levels to measure the judgments and 
decreasing values from 3 to 1 (relevant, moderately relevant, 
not relevant) to evaluate the relevance, comprehensiveness, 
and clarity of each item of the protocol. 
Categories scoring 3 (relevant) in the Likert scale that had 
the evaluation approved in a favorable consensus of 75% 
were considered for the statistic treatment. This agreement in-
dex was based on other validation studies(9-10).
After the analysis of the items, the protocol was reformu-
lated and sent back to the experts; they had 30 more days, 
between March and April 2013, to return it. However, only 
34 experts returned the reassessed protocol, consisting in the 
second stage of the Delphi.
Initially, the protocol presented 15 items of care to patients 
using a VAD. However, after the two Delphi stages, five items 
were excluded for being considered not relevant to the theme.
Statistics and analysis of results
Data were entered in an Excel spreadsheet, and the soft-
ware SPSS 17.0 was used for calculation; a level of signifi-
cance of 5% was applied and observed. Descriptive statistics 
(frequency, mean, median, and standard deviation) and the 
Kappa index were used to assess the level of coincidence 
among the evaluators and the consistency of the experts in 
relation to keeping or not certain items of the instrument.
The content validity index (CVI), consisting in the calculation 
of the number of evaluators that considered the item relevant by 
the total of evaluators, was conducted to measure the agreement 
of the experts regarding the representativeness of the items in re-
lation to the approached content. The items that presented con-
vergent opinions by the evaluators with the established level of 
significance (CVI > 0.75 and Kappa > 0.70) were considered 
relevant. The original protocol was made up of 15 items related to 
the care of patients using a VAD. After the evaluation, four items 
were excluded as they were considered not pertinent to the theme.
RESULTS
All the 42 experts that made up the first stage of Delphi 
were Spanish nursing professionals of a teaching hospital in 
the city of Valencia, consisting in 32 (69.5%) women and 10 
(21.8%) men, with mean age of 43.6 years (+ 8.7), of whom 
4 (8.7%) had a doctorate degree, 12 (26.1%) had a master’s 
degree, 6 (13.0%) had studies presented in scientific events in 
the area of this study, 5 (10.9%) had publications in journals, 
and 1 (2.1%) had a master’s thesis in the area of this study. 
Table 1 – Items of the nursing care protocol to patients with a ventricular assist device considered valid by the experts/evalu-
ators in the two Delphi stages, Valencia, Spain, 2013
Variables Yes No Total Kappa CVI
n % n % n %
Clarification of the patient in relation to the risk-benefit ratio of the device 28 83.0 6 17 34 100.0 0.87 0.94
Equipment functionality monitoring 31 89.4 3 10.6 34 100.0 1 1
Monitoring of HR, MAP, RAP, LAP, CO, HI, SvO2 27 78.7 7 21.3 34 100.0 0.80 0.89
Monitoring of pulse oximetry, urine output, temperature 30 87.2 4 12.8 34 100.0 0.96 0.98
Use of pressure relief mattresses to prevent pressure ulcers 31 89.4 3 10.6 34 100.0 1     1
Maintenance of the patient in horizontal decubitus position and contraindication of 
the changing of decubitus 28 83.0 6 17.0 34 100.0 0.77 0.87
Conducting laboratorial exams such as gasometry (arterial gas analysis), creatinine, urea, 
lactate, sodium, potassium, magnesium: 6∕6 hours 29 85.1 5 14.9 34 100.0 0.92 0.91
Collection of total proteins and albumin, control of bilirubin, liver enzymes and 
amylase, fibrinogen and D-dimer: daily 28 83.0 6 17.0 34 100.0 0.83 0.91
Collection of blood culture 25 72.3 9 27.7 34 100.0 0.76 0.87
Administration of prophylactic antibiotic therapy during the seven first days 28 83.0 6 17.0 34 100.0 0.80 0.89
Collection of tracheal secretion culture and surgical wound culture: in case of presence of 
secretion 27 80.9 7 19.1 34 100.0 0.92 0.96
Note: HR = Heart rate; MAP = Mean arterial pressure; RAP = Right atrium pressure; LAP = Left atrium pressure; CO = Cardiac output; HI = Heart index; SvO2 
= Venous oxygen saturation; CVI = Content validity index
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DISCUSSION
The Brazilian Ministry of Health affirms that protocols are 
recommendations systematically developed to support the man-
agement of a health problem in a specific clinical circumstance, 
preferably based on the best scientific data. These protocols are 
important tools for upgrades in the health area, being used to 
reduce the inappropriate variations in clinical practice(17).
Therefore, the implementation of clinical protocols to meet 
specific demands is extremely necessary. The clinical proto-
col for patients using a VAD should be instituted immediately 
after the indication for implantation of the device to enable 
consistency in the care planning. 
Patients with HF and hemodynamically unstable using a VAD 
are high-complexity, critical patients requiring clinical follow-up 
and systematic care. This follow-up should be performed by the 
whole multidisciplinary team, aiming at care integration. 
Systematized care is based on the need of teamwork for prop-
er patient care. The present study emphasizes that the nursing 
staff represents about 70% of the whole staff in the health area 
and its professional premise is to establish comprehensive care 
through the 24 hours of care at the bedside and out of the bed, 
in mechanisms of work shift scales and with assignments of tasks 
well established by the relevant legislation in the different work 
categories (nurses, nursing technicians, and nursing aides)(11).
 The complexity of the nursing care provided in an in-
tensive care unit, the dynamicity, and the monitoring of in-
formation that determine and change the therapy proposed 
to patients require adequate and constant training of these 
professionals(11). Therefore, this study emphasizes the impor-
tance of developing and validating care protocols for critical 
patients by using appropriate methodologies to this process.
After two rounds of the Delphi technique in the present study 
it was observed that the item referring to the clarification of the 
patients’ doubts in relation to the risk-benefit ratio of the device 
was validated. Psychosocial factors related to the patients and 
their family result from an adequate guidance by the health pro-
fessionals in relation to the procedures that will be conducted or 
in relation to the reason and importance of each procedure in 
order to prepare the patient to initiate the therapy. Thus, anxiety 
is reduced and humanized care is provided.
Regarding the monitoring of the functionality of a VAD, a high 
level of agreement was verified among the experts. This is certainly 
an imperative assessment, as it depicts the care with equipment, 
defects, or maladjustments in the monitor of the console of each 
device, and obstructed or collapsed catheters(12). These factors may 
lead to malfunction or cause delay or discontinuance of the therapy.
In relation to the importance of the hemodynamic moni-
toring, HR, MAP, CO, SvO2, and pulse oximetry are widely 
discussed data in the literature(4,6) aiming at obtaining accu-
rate data from critical patients using a VAD, corroborating 
the positive consensus of the experts in this study. However, 
the verification of the pulse, urine output, and temperature 
also presented favorable consensus among the experts. It 
is important to mention that the indication to monitor the 
physiological state of critical patients is an important fact for 
the achievement of a better regulation of the medical therapy 
and data on patients’ evolution.
Chart 1 – Nursing care protocol for patients with a ventricular assist device
Action Description
1. Clarification of the patient in relation to the risk-benefit ratio 
of the device Aimed at providing humanized care and reducing patient anxiety
2. Equipment functionality monitoring Prevention of console-related problems. Prevention of possible obstruction of the system.
3. Monitoring: HR, MAP, RAP, LAP, CO, HI, SvO2. Aimed at obtaining appropriate monitoring and clinical compensation.
4. Monitoring of pulse oximetry, urine output, temperature. Aimed at obtaining appropriate monitoring and clinical compensation.
5. Use of pressure relief mattresses to prevent pressure ulcers. Redistribute and soften the pressure of a body on a surface and prevent skin injuries.
6. Maintenance of the patient in horizontal decubitus position 
and contraindication of changing of decubitus. Avoid obstruction and/or rupture in the system used by the device.
7. Assessment of laboratorial exams such as gasometry, creatinine, 
urea, lactate, sodium, potassium, magnesium: 6∕6 hours.
Analyze the occurrence of adverse prognoses, such as renal and 
respiratory changes and ineffective tissue perfusion.
8. Collection of total proteins and albumin, control of bilirubin, 
liver enzymes and amylase, fibrinogen and D-dimer: daily. Analyze the occurrence of liver complications and coagulopathies.
9. Administration of prophylactic antibiotic therapy during the 
seven first days as prescribed. Perform the prophylaxis of infections related to the surgical wound.
10. Collection of tracheal secretion culture and surgical 
wound culture: in case of presence of secretion.
Identify microorganisms that cause infections in the surgical wound 
for an appropriate antibiotic therapy, if necessary.
Note: HR = Heart rate; MAP = Mean arterial pressure; RAP = Right atrium pressure; LAP = Left atrium pressure; CO = Cardiac output; HI = Heart index; SvO2 
= Venous oxygen saturation.
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The prevention of pressure ulcers in patients using a VAD re-
quires that nurses have competence to assess the inherent condi-
tions of these patients that predispose them to tissue lesions by 
pressure, such as immobility, coronary disease, arterial hyperten-
sion, vasculopathies, and use of antibiotic therapy, as well as in 
the implementation of measures to prevent them(13). Thus, the use 
of pressure relief mattresses presented a high index of agreement 
and acceptance among the experts of the protocol developed in 
this study. Water, air, or special gels are among the fluids used in 
such applications. Also, there are models that use alternating pres-
sure between the body and the mattress through the insufflation 
and disinflation of compressed air in pneumatic pockets(14).
The use of pressure relief mattresses is suggested to redis-
tribute and soften the pressure of the body on a given surface, 
as well as to prevent skin lesions and ensure a more com-
fortable support of the body(13), especially in relation to the 
relevance of an alternative method to prevent pressure ulcers, 
as the change of decubitus (consisting in the main approach 
adopted for this purpose) is contraindicated for patients using 
a VAD. These patients should remain in horizontal decubitus 
as decubitus change may generate complications for them, 
such as rupture or obstruction of the device, hemolysis, bleed-
ing, thrombocytopenia, and arterial or venous thrombosis(15).
Laboratory analysis of exams such as arterial blood gas analy-
sis and evaluation of creatinine, urea, lactate, sodium, potassium, 
and magnesium indices at intervals of 6 hours also presented 
favorable indication in the protocol. Hyponatremia and impaired 
kidney function are adverse prognostic predictors in HF. Impaired 
kidney function may occur due to several reasons: comorbidities 
(diabetes mellitus, systemic arterial hypertension), cardiac output 
reduced by heart disease, or as an effect of the treatment (use 
of diuretics, angiotensin II converting enzyme inhibitors, and 
angiotensin receptor blockers). Hypokalemia may cause fatal ar-
rhythmias. On the other hand, hyperkalemia may complicate the 
concomitant treatment with angiotensin II-converting enzyme 
inhibitor and angiotensin-receptor blockers, β-blockers, and spi-
ronolactone, requiring therapeutic adjustment(16).
According to the Brazilian guidelines on acute heart failure, 
arterial blood gas analysis should be requested for all patients 
with severe respiratory distress or signs of low output. The exam 
enables the analysis of oxygenation (PO2) and respiratory func-
tion (PCO2), as well as acid-base balance (pH) analysis. It should 
be conducted along with the analysis of lactate, and in case of 
occurrence of acidosis and hyperlactatemia due to ineffective tis-
sue perfusion a poor prognosis is established to the patient using 
a VAD as they may be presenting an evolution to cardiogenic 
shock, even before the development of arterial hypertension. 
Likewise, retention of CO2 indicates severe respiratory distress
(16).
The daily collection and laboratory analysis of total proteins 
and albumin, as well as the control of bilirubin and liver enzymes, 
is important in the prevention of HF-related hepatic complications 
that these samples may offer(18). Cardiac cirrhosis is currently clini-
cally defined by the triad of right-ventricular hepatomegaly, ascites 
with high protein content, and high albumin gradient between 
the serum and the ascites fluid. Cardiogenic ischemic hepatitis is 
characterized by the increased serum level of transaminases and 
bilirubin after acute and severe fall in cardiac output. Moreover, 
elevation of liver enzymes may be an indicative of hepatic con-
gestion and/or hypoperfusion(18). The amylase enzyme analysis 
enables a diagnosis of acute pancreatitis or renal failure, and 
such complications may lead to clinical hypovolemic shock in 
individuals that should not be subjected to this risk due to the 
underlying heart disease, as it happens with patients using a VAD. 
Regarding the fibrinogen (precursor of fibrin) and the d-dimer (a 
product of the degradation of fibrin by the plasmin), data on their 
serum levels may support the diagnosis of diseases and conditions 
that cause hypercoagulability, and may be useful as a risk marker 
of deep venous thrombosis and pulmonary thromboembolism in 
patients presenting cardiovascular alteration(16,18).
The correct identification of microorganisms that cause sur-
gical wound infection by means of the collection of culture is 
necessary in order to guide the professional behavior in rela-
tion to the antibiotic therapy(19).
Antibiotic prophylaxis deserves special attention, because 
if it is conducted inadequately it will not contribute to prevent 
the infection and may lead to undesirable effects, including 
the selection of resistant microbiota, superinfections, and in-
creased incidence of adverse effects to antibiotics(20).
In addition to the care items related to the use of a VAD point-
ed out in this protocol, other items should be considered in the 
care of critical patients, including nutritional support and patient 
pain assessment through facial or visual numeric scales and an-
algesia(20-21). Prevention of infectious processes should also be 
a goal to be achieved, especially in relation to patients using 
mechanical ventilation. Currently, oral hygiene with 0.12% 
chlorhexidine is addressed in the literature as an important tool 
to prevent pulmonary infections(19), as well as the adequate bed 
positioning and prevention of gastric reflux as a way of prevent-
ing pneumonia associated with mechanical ventilation(20).
The protocol content validation was specifically focused on 
patients using a VAD, covering some items that are not es-
sentially important to be assessed, especially regarding such a 
complex patient for the standardization of a care plan(22). 
The use of protocols, severity scores, and rules may support 
the care plan and assessment of patients using a VAD. The FAST 
HUG mnemonic rule developed in 2005 by JL Vincent is indi-
cated for these patients as it covers all their needs by means of a 
systematized approach to support health professionals, especial-
ly those working in intensive care, to assess important aspects 
in the care of critical patients(23). It is important to mention that 
all the items with solid evidence of validation in the VAD pro-
tocol should be included in the nursing prescription due to its 
relevance reported in the literature, but further studies of clinical 
validation will be necessary to verify this hypothesis.
Study limitations
The present study did not approach themes related to the clini-
cal protocols of anticoagulation and, consequently, of risk of bleed-
ing in which these variables may be studied in a specific protocol.
Contributions for the fields of nursing, health or public policies
 Considering the technological advance in the health area that 
is directly related to the care provided by nursing to patients us-
ing ventricular assist devices, the present study may collaborate 
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in the implementation and application of a standardized clinical 
protocol, increasing effectiveness and safety for care practice.
CONCLUSION
Based on the content validation performed by experts, a 
protocol containing ten items related to the care of patients 
using a VAD was developed to guide health professionals in 
the care of these patients and in the systematization of nursing 
care, promoting quality care.
Although not contemplated in the protocol, other impor-
tant care-related items include: adequate nutritional support, 
patient pain assessment, correct analgesia, and prevention of 
infectious processes.
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